万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://www.springer.com/journal/13318
3、投稿网址：https://www.editorialmanager.com/ejdr
4、官网邮箱：
kiruthika.gunaselvam@springernature.com
（有关投稿问题，同行评审过程或手稿状态的查询）
Albert.Singh@springer.com
（有关稿件出版或出版后更正问题的查询）
jasbir.singh@springer.com
（有关期刊的任何其他查询或提交前的查询）
5、期刊刊期：双月刊，逢双月出版。
2021年5月7星期五
投稿须知
【官网信息】
Submission guidelines
Instructions for Authors
Please read these instructions in conjunction with the "Additional Information for Authors" document. This document, together with other useful submission documentation, can be found by following the "Important Information for Authors" link:
Important Information for Authors
Types of Papers
Please note: The word counts given below do not include the abstract, references, figure legends or table captions.
Review Article. Word count up to 8000. Provides an authoritative, balanced, comprehensive, fully referenced and critical review of the literature.
Leading Article. Word count up to 4000. Provides a short, balanced overview of the current state of development of an emerging area.
Current Opinion. Word count 1500 to 4000. Places an area in perspective given that it is of current international interest and a consensus has not yet been reached; therefore, the arguments presented may be controversial, but at the same time must be balanced and rational.
Systematic Review. Word count up to 10,000. Collates all empirical evidence that fits pre-specified eligibility criteria to answer a specific research question. It uses explicit, systematic methods that are selected with a view to minimizing bias, thus providing reliable findings from which conclusions can be drawn and decisions made. Please follow the reporting guidelines of PRISMA.
Original Research. The European Journal of Drug Metabolism and Pharmacokinetics will consider all aspects of pre-clinical and clinical pharmacokinetics, including drug disposition, drug metabolism, drug transport, drug interactions, bioavailability and biopharmacy. The journal welcomes publications in the field of pharmacokinetic modeling. Analytical methods validation linked with a pharmacokinetic study will also be considered. Such studies should be submitted as an Original Research Article (word count up to 4000), following the reporting guidelines of CONSORT for randomized controlled trials, and STROBE for purely observational studies. Reports of studies that are smaller in scale and, thus, may report pilot data warranting further investigation, may also be considered for publication; such articles should be submitted as Short Communications.
Letter to the Editor. Word count up to 1000. Comment on an article published recently in the journal; a response to the comments would normally be sought from the authors of the original article and published in the same issue, where possible.
Editorial/Commentary. Word count up to 1500. A brief opinion piece on a current topic of high interest.
Practical Application. Word count up to 2000. Describes the application of pharmacokinetic and pharmacodynamic principles in everyday clinical practice and patient care.
Editorial Procedure
Internal Review by Editorial Staff: The journal editor will perform an initial appraisal of each manuscript. If your paper has been peer reviewed by another journal as part of a prior submission, the journal editor will also assess any previous editorial/referee comments and how these have been dealt with as part of the appraisal process. If your manuscript is considered unsuitable for the journal to which it has been submitted, it may be assessed for suitability for publication in other Adis journals by appropriate editors. However, it will not be progressed to external peer review for an alternative journal without your permission.
External Peer Review: Peer reviewer identities are kept confidential, but author identities are known to the reviewers. Peer reviewers are asked to disclose potential conflicts of interests that may affect their ability to provide an unbiased review of an article. The majority of manuscripts will require some degree of revision following peer review before they can be accepted for publication. The final decision on acceptability for publication lies with the journal editor.
Copy Editing: All accepted manuscripts are copy edited. This process addresses general publishing considerations, such as layout of tables and figures, housestyle and clarity of expression. Authors will receive proofs following editing for their approval and sign off. It should be noted that the responsibility for checking the technical accuracy and consistency of data within the article rests with the authors
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Please note:
Please note that, for some articles (particularly, systematic reviews and original research articles), 250 words may not be sufficient to provide all necessary information in the abstract. Therefore, the abstract length can be increased from the 250-word limit (to up to 450 words) if the topic dictates, and to allow full compliance with the relevant reporting guidelines.
……
